All Relations between Schizophrenia and cannabis

Publication Sentence Publish Date Extraction Date Species
Delali Fiagbe, Ama Kyerewaa Edwin, Eugene K Dordoye, Dzifa Dellor, Adwoa Gyamera, Emmanuel Dziworn. The Ethical Dilemma of Balancing Confidentiality and Duty to Protect: A Case Report of Comorbid Schizophrenia and Cannabis Use Disorder with Homicidal Thoughts. Nigerian medical journal : journal of the Nigeria Medical Association. vol 64. issue 3. 2024-07-08. PMID:38974070. the ethical dilemma of balancing confidentiality and duty to protect: a case report of comorbid schizophrenia and cannabis use disorder with homicidal thoughts. 2024-07-08 2024-07-11 Not clear
Delali Fiagbe, Ama Kyerewaa Edwin, Eugene K Dordoye, Dzifa Dellor, Adwoa Gyamera, Emmanuel Dziworn. The Ethical Dilemma of Balancing Confidentiality and Duty to Protect: A Case Report of Comorbid Schizophrenia and Cannabis Use Disorder with Homicidal Thoughts. Nigerian medical journal : journal of the Nigeria Medical Association. vol 64. issue 3. 2024-07-08. PMID:38974070. this is a report of a 29-year-old female with a history of schizophrenia and cannabis use disorder who presented with auditory hallucinations that asked her to kill her immediate supervisor. 2024-07-08 2024-07-11 Not clear
Emma C Johnson, Isabelle Austin-Zimmerman, Hayley H A Thorpe, Daniel F Levey, David A A Baranger, Sarah M C Colbert, Ditte Demontis, Jibran Y Khokhar, Lea K Davis, Howard J Edenberg, Marta Di Forti, Sandra Sanchez-Roige, Joel Gelernter, Arpana Agrawa. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2024-06-21. PMID:38906991. individuals with schizophrenia frequently experience co-occurring substance use, including tobacco smoking and heavy cannabis use, and substance use disorders. 2024-06-21 2024-06-24 Not clear
Emma C Johnson, Isabelle Austin-Zimmerman, Hayley H A Thorpe, Daniel F Levey, David A A Baranger, Sarah M C Colbert, Ditte Demontis, Jibran Y Khokhar, Lea K Davis, Howard J Edenberg, Marta Di Forti, Sandra Sanchez-Roige, Joel Gelernter, Arpana Agrawa. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2024-06-21. PMID:38906991. we explored the relationships between schizophrenia (scz; european ancestry n = 161,405; african ancestry n = 15,846), cannabis use disorder (canud; european ancestry n = 886,025; african ancestry n = 120,208), and ever-regular tobacco smoking (smk; european ancestry n = 805,431; african ancestry n = 24,278) using the largest available genome-wide studies of these phenotypes in individuals of african and european ancestries. 2024-06-21 2024-06-24 Not clear
Mary F Brunette, Robert M Roth, Christi Trask, Jibran Y Khokhar, James C Ford, Soo Hwan Park, Sara M Hickey, Thomas Zeffiro, Haiyi Xi. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder. Schizophrenia bulletin. 2024-06-20. PMID:38900958. randomized laboratory study of single-dose cannabis, dronabinol, and placebo in patients with schizophrenia and cannabis use disorder. 2024-06-20 2024-06-23 Not clear
Mary F Brunette, Robert M Roth, Christi Trask, Jibran Y Khokhar, James C Ford, Soo Hwan Park, Sara M Hickey, Thomas Zeffiro, Haiyi Xi. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder. Schizophrenia bulletin. 2024-06-20. PMID:38900958. up to 43% of people with schizophrenia have a lifetime cannabis use disorder (cud). 2024-06-20 2024-06-23 Not clear
Meghan J Chenowet. Cracking the chicken and egg problem of schizophrenia and substance use: Genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2024-06-11. PMID:38862577. cracking the chicken and egg problem of schizophrenia and substance use: genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking. 2024-06-11 2024-06-14 chicken
Nikhil Nowbath, Nada Abdelatif, Gian Lipp. Comparing the medication costs of treating patients with schizophrenia who use cannabis with those who do not. The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa. vol 30. 2024-05-10. PMID:38726333. comparing the medication costs of treating patients with schizophrenia who use cannabis with those who do not. 2024-05-10 2024-05-27 Not clear
Nikhil Nowbath, Nada Abdelatif, Gian Lipp. Comparing the medication costs of treating patients with schizophrenia who use cannabis with those who do not. The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa. vol 30. 2024-05-10. PMID:38726333. cannabis use is more prevalent among people with schizophrenia than in the general population. 2024-05-10 2024-05-27 Not clear
Kennadi Johnson, Abby J Weldon, Melissa A Burmeiste. Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen. Frontiers in psychiatry. vol 15. 2024-05-08. PMID:38716117. differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen. 2024-05-08 2024-05-27 Not clear
Kennadi Johnson, Abby J Weldon, Melissa A Burmeiste. Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen. Frontiers in psychiatry. vol 15. 2024-05-08. PMID:38716117. moreover, medication adherence is poor, and individuals with schizophrenia choose to self-medicate with illicit substances, including cannabis. 2024-05-08 2024-05-27 Not clear
Kennadi Johnson, Abby J Weldon, Melissa A Burmeiste. Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen. Frontiers in psychiatry. vol 15. 2024-05-08. PMID:38716117. it is well-established that the delta-9-tetrahydrocannabinol (delta-9-thc) component of cannabis elicits psychotomimetic effects at high doses; worsens schizophrenia-related psychosis; commonly develops into cannabis use disorder in individuals with schizophrenia; and increases the risk of earlier-onset schizophrenia symptoms in those harboring genetic susceptibility. 2024-05-08 2024-05-27 Not clear
Kennadi Johnson, Abby J Weldon, Melissa A Burmeiste. Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen. Frontiers in psychiatry. vol 15. 2024-05-08. PMID:38716117. however, individuals with schizophrenia commonly use cannabis and cannabis derivatives such as cannabidiol (cbd). 2024-05-08 2024-05-27 Not clear
Aishwariya Brigit George, Abhishek Gupta, Raka Jain, Mamta Sood, Siddharth Sarka. Serum brain-derived neurotrophic factor level and its relation with cannabis use disorder and schizophrenia: A cross-sectional exploratory study in patients at a tertiary care hospital. Indian journal of pharmacology. vol 56. issue 2. 2024-04-30. PMID:38687312. serum brain-derived neurotrophic factor level and its relation with cannabis use disorder and schizophrenia: a cross-sectional exploratory study in patients at a tertiary care hospital. 2024-04-30 2024-05-03 Not clear
Carsten Hjorthøj, Anne Stürup, Mette Karlsen, Helene Speyer, Merete Osler, Dost Ongur, Merete Nordentof. Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study. Psychological medicine. 2024-04-04. PMID:38571303. evidence suggests that cannabis may be a causal factor for development of schizophrenia. 2024-04-04 2024-04-06 Not clear
Carsten Hjorthøj, Anne Stürup, Mette Karlsen, Helene Speyer, Merete Osler, Dost Ongur, Merete Nordentof. Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study. Psychological medicine. 2024-04-04. PMID:38571303. we aimed to investigate whether use of antipsychotic medication, benzodiazepines, and psychiatric service use differs among patients with schizophrenia depending on whether psychosis was precipitated by a diagnosis of cannabis use disorder (cud). 2024-04-04 2024-04-06 Not clear
Natalia Mansur Haddad, Leonardo Peroni De Jesus, Mauricio Serpa, Martinus Van De Bilt, Leda Talib, Alana Costa, Wagner Gattaz, Alexandre Andrade Loc. Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication. European archives of psychiatry and clinical neuroscience. 2024-03-19. PMID:38502208. endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication. 2024-03-19 2024-03-23 Not clear
Mehmet Hamdi Örü. Letter to the editor: "Associative learning and facial expression recognition in schizophrenic patients: Effects of social presence" and "Does cannabis affect cognitive functioning in patients with schizophrenia?" Schizophrenia research. Cognition. vol 36. 2024-02-28. PMID:38414561. letter to the editor: "associative learning and facial expression recognition in schizophrenic patients: effects of social presence" and "does cannabis affect cognitive functioning in patients with schizophrenia?" 2024-02-28 2024-03-01 Not clear
Emma C Johnson, Isabelle Austin-Zimmerman, Hayley Ha Thorpe, Daniel F Levey, David Aa Baranger, Sarah Mc Colbert, Ditte Demontis, Jibran Y Khokhar, Lea K Davis, Howard J Edenberg, Marta Di Forti, Sandra Sanchez-Roige, Joel Gelernter, Arpana Agrawa. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking. medRxiv : the preprint server for health sciences. 2024-01-31. PMID:38293235. individuals with schizophrenia frequently experience co-occurring substance use, including tobacco smoking and heavy cannabis use, and substance use disorders. 2024-01-31 2024-02-02 Not clear
Emma C Johnson, Isabelle Austin-Zimmerman, Hayley Ha Thorpe, Daniel F Levey, David Aa Baranger, Sarah Mc Colbert, Ditte Demontis, Jibran Y Khokhar, Lea K Davis, Howard J Edenberg, Marta Di Forti, Sandra Sanchez-Roige, Joel Gelernter, Arpana Agrawa. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking. medRxiv : the preprint server for health sciences. 2024-01-31. PMID:38293235. we explored the relationships between schizophrenia (scz), cannabis use disorder (canud), and ever-regular tobacco smoking (smk) using the largest available genome-wide studies of these phenotypes in individuals of african and european ancestries. 2024-01-31 2024-02-02 Not clear